Safety and Tolerability of ACU-4429

A Single Center, Randomized, Double-Masked, Dose-Escalating, Placebo-Controlled Study of the Safety and Tolerability ACU-4429 in Healthy Volunteers

The purpose of this study is to evaluate the safety and tolerability of a new investigational drug (ACU-4429) in healthy human volunteers.

Inclusion Criteria:

• Is male or female with age ≥ 55 and ≤ 80 years at the time of consent
• Is healthy as determined by medical history and physical examination

Exclusion Criteria:

• Is receiving or has recently received treatment with a medication disallowed per the protocol